SCHEMBL26659382

SCHEMBL26659382

C/C(=C\C(=O)O)C(=O)Nc1cccc(O)c1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ PARP1 P09874 1/20 0.47
▸ CA12 O43570 2/20 0.46
▸ CA1 P00915 2/20 0.46
▸ CA2 P00918 2/20 0.46
▸ CA7 P43166 2/20 0.46
▸ CA9 Q16790 2/20 0.46
▸ CA14 Q9ULX7 2/20 0.46
▸ LPAR2 Q9HBW0 1/20 0.45
▸ LPAR3 Q9UBY5 1/20 0.45
▸ DHODH Q02127 1/20 0.43
▸ TRPM8 Q7Z2W7 1/20 0.43
▸ PLK1 P53350 1/20 0.43
▸ PLK3 Q9H4B4 1/20 0.43
▸ GAA P10253 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26659445 1.00 KDM4E (0.50) KDM4EALDH1A1CYP1A2CYP2C19PARP1
SCHEMBL12850382 0.84 GAA (0.58) KDM4EALDH1A1CYP1A2CYP2C19PARP1
SCHEMBL5177083 0.84 GAA (0.58) KDM4EALDH1A1CYP1A2CYP2C19PARP1
SCHEMBL15412073 0.84 GAA (0.58) KDM4EALDH1A1CYP1A2CYP2C19PARP1
SCHEMBL26659399 0.79 KDM4E (0.56) KDM4EALDH1A1CYP1A2CYP2C19PARP1
SCHEMBL26659418 0.79 KDM4E (0.56) KDM4EALDH1A1CYP1A2CYP2C19PARP1
SCHEMBL4959476 0.79 CA12 (0.57) KDM4EALDH1A1CYP2C19CA12CA1
SCHEMBL5174596 0.75 RAB9A (0.65) KDM4EALDH1A1CYP1A2CYP2C19PARP1
SCHEMBL26659458 0.73 KDM5A (0.53) KDM4EALDH1A1CYP1A2CYP2C19PARP1
SCHEMBL26659388 0.73 KDM5A (0.53) KDM4EALDH1A1CYP1A2CYP2C19PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365730-A1 HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF KANEKA CORPORATION (JP) 2023-11-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365730-A1 HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF KDM5C, DHX15, KDM5A KDM4E 135/4885ALDH1A1 476/4885CYP1A2 519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback